From CNBC Africa

Doctors Without Borders (MSF) will start clinical trials for Ebola in West Africa in December.

The trials will take place in three separate Ebola treatment centers and will be carried out by three different research teams.

The teams are: The French National Institute of Health and Medical Research (INSERM), who will make use of the antiviral drug favipiravir. The University of Oxford will lead, on behalf of the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), the trial of the antiviral drug brincidofovir. And the Antwerp Institute of Tropical Medicine (ITM) will look at convalescent blood and plasma therapy

Written by Rutendo Nyamuda/Read more at CNBC Africa